Press Releases
Neurocrine Biosciences to Present at the Nomura Biotechnology Conference NEUROCRINE BIOSCIENCES
Neurocrine Biosciences to Present at the Nomura Biotechnology ConferenceLive Audio Webcast will be on November 6 2014 PR Newswire SAN DIEGO...
News
Bristol-Myers Squibb expands biologics manufacturing agreement with Lonza
Bristol-Myers Squibb (BMS) has expanded its existing biologics manufacturing agreement with Switzerland-based Lonza. The contract is expanded for the production...
Research Insight
AstraZeneca’s type 2 diabetes treatment Xigduo XR obtains FDA approvalAstraZeneca’s type 2 diabetes treatment Xigduo XR obtains FDA approval
British-Swedish drugmaker AstraZeneca has received approval from US Food and Drug Administration (FDA) for its once-daily Xigduo XR to treat adult patients...
Research Insight
Pfizer’s Trumenba gets FDA accelerated approval to treat Meningococcal B disease
US-based drugmaker Pfizer has received accelerated approval from US Food and Drug Administration (FDA) for its Trumenba to treat Meningococcal B disease...
Clinical Trials
TxCell achieves positive results for Col-Treg in a model of autoimmune uveitis
TxCell set for phase I/II proof of principle clinical study in Q2 2015 for its second therapeutic candidate in this rare eye disease ...
Press Releases
TxCell to present on T Cellular Therapy for Autoimmune Diseases at the 7th National Bio-Therapy Conference 2014, China
TxCell SA (FR0010127662 – TXCL), a biotechnology company developing innovative, personalized cell-based immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and...
News
ViiV Healthcare’s HIV drug Triumeq obtains Canadian approval
ViiV Healthcare, a joint venture of GlaxoSmithKline (GSK), Pfizer and Shionogi, has obtained approval in Canada, for its Triumeq (dolutegravir) 50mg, abacavir...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read